Company
OrsoBio
OrsoBio is on a mission to redefine the treatment of metabolic diseases by addressing their root cause.
Also known as OrsoBio, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- OrsoBio, Inc
- orsobio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders.
Funding snapshot
- Total raised
- $125MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $40M2024-08-14
Funding rounds
- Round, 2024
- $40M2024-08-14, SEC form D sold, 7 investors
- Round, 2023
- $84.6M2023-10-27, SEC form D sold, 6 investors
Loading relationship preview